Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 152Lymphoid 19Thoracic 11Other solid neoplasm 8Gynecologic 8Genitourinary 5Tumor-Agnostic 4Other hematologic neoplasm 3Head & Neck 3Sarcoma 2Dermatologic 2CNS 2Breast 2

Conditions

Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Endometrial Neoplasms 1Desmoid Tumors 1Dendritic Cell Sarcoma, Interdigitating 1Craniopharyngioma 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Adenomatous Polyposis Coli 1

Interventions

Specimen Handling 38Magnetic Resonance Spectroscopy 32Cyclophosphamide 27Doxorubicin 24Temozolomide 23Biopsy 23pembrolizumab 22Radiotherapy 19X-Rays 18Radiation 18Nivolumab 16Vincristine 14Irinotecan 13Phantoms, Imaging 12Ifosfamide 12Gemcitabine 11fludarabine 10cabozantinib 10atezolizumab 10Ipilimumab 10Bevacizumab 9liposomal doxorubicin 8Paclitaxel 8Immunoglobulin G 8Surgical Procedures, Operative 7Dactinomycin 7Carboplatin 7palbociclib 6olaparib 6durvalumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Oxaliplatin × Sarcoma × 90 days × Clear all
NCT05919264 2026-05-12

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc.

Phase 1/2 Recruiting
595 enrolled
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT07570823 2026-05-06

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Sinocelltech Ltd.

Phase 3 Not yet recruiting
101 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡